Concepedia
Statistics
Publications
5
Citations
1.1K
H-Index
Active since
2009
Affiliations
Eli Lilly (United States)(Current)
Eli Lilly (Netherlands)
Amsterdam UMC Location Vrije Universiteit Amsterdam
Sahlgrenska University Hospital
Helsinki University Hospital
Rimma M. Shaginian is an author at Eli Lilly (United States) specializing in medicine, endocrinology, and diabetes mellitus.
Publications per year
2009–2014
One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients
Mathijs C. Bunck, Michaëla Diamant, A. H. Corner et al. · Diabetes Care · 2009 · 387 citations · Full text
Medicine, Endocrinology, Pharmacology +15
Effects of Exenatide on Measures of β-Cell Function After 3 Years in Metformin-Treated Patients With Type 2 Diabetes
Mathijs C. Bunck, A. H. Corner, Björn Eliasson et al. · Diabetes Care · 2011 · 239 citations · Full text
Medicine, Endocrinology, Pharmacology +17
Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes
Michaëla Diamant, Michael A. Nauck, Rimma M. Shaginian et al. · Diabetes Care · 2014 · 222 citations
Medicine, Endocrinology, Pharmacotherapy +17
Exenatide Affects Circulating Cardiovascular Risk Biomarkers Independently of Changes in Body Composition
Mathijs C. Bunck, Michaëla Diamant, Björn Eliasson et al. · Diabetes Care · 2010 · 156 citations · Full text
One-year treatment with exenatide vs. Insulin Glargine: Effects on postprandial glycemia, lipid profiles, and oxidative stress
Mathijs C. Bunck, A. H. Corner, Björn Eliasson et al. · Atherosclerosis · 2010 · 135 citations
1–5 of 5